Background Controversial evidence exists as to whether thrombolytic therapy reduces the incidence of left ventricular thrombus in acute myocardial infarction and, if so, how this relates to successful reperfusion.
Introduction
Anterior myocardial infarction is frequently associated with left ventricular thrombus' . The high risk of systemic embolization (20% approximately) suggests the use of anticoagulants in patients with anterior myocardial infarction and documented thrombus' 5 " 71 , but whether thrombolytic agents prevent its formation and reduce the incidence of embolization is not clear by (1) direct lysis of the thrombus (2) reduction of myocardial damage by early reperfusion. In a large cohort of patients with acute myocardial infarction, we assessed the effects of systemic thrombolysis on the prevalence of left ventricular thrombosis. In particular, we studied the role of recanalization of the infarctrelated artery in preventing the development of left ventricular thrombosis as well as the relationship between the thrombus and the extent of myocardial damage.
Methods

Study patients
We prospectively studied 418 consecutive patients admitted to our Unit between November 1990 and May 1994 and presenting with a first acute myocardial infarction. We excluded patients aged more than 75 years and those with inadequate echocardiograms, complete left bundle branch block, primary myocardial or valvular heart disease and systemic illnesses that could affect left ventricular function or long-term prognosis.
All study patients had been admitted to the Coronary Care Unit within 48 h of the onset of symptoms and had a proven diagnosis of acute myocardial infarction based on history, ECG changes and abnormal increases in cardiac enzymes. A 16-lead electrocardiogram (standard precordial and peripheral leads, V 7 , V g and V 3 r, V 4 r) was obtained from all patients immediately after admission and then at least every 4 h, together with serum enzyme determinations. Additional electrocardiograms and blood samples were obtained whenever appropriate. An early peak of the creatine kinase release curve was considered to have occurred when observed within 12 h of the onset of symptoms.
Of the 418 patients enrolled (322 males, mean age 57-7 ± 9-6, range 19-75 years), in 333 there was ST segment elevation of 1 mm or more in at least two adjacent leads; 85 had T wave inversion or ST depression. Infarct location was established as the site of electrocardiographic alterations and of regional wall motion abnormalities recorded on the two-dimensional echocardiogram. The ST segment elevation was inferior in 102 patients, infero-postero-lateral in 50, and anterior in 181. In all cases, there was concordance between the electrocardiographic site of necrosis and regional wall motion abnormalities.
Anterior myocardial infarction was defined as large when (1) the ST segment elevation involved lead I or aVL or both, as well as at least four precordial leads and (2) occlusion, or stenosis, or wall irregularities of the proximal segment of the left anterior descending coronary artery (before the first septal perforator) was observed at angiography.
A larger anterior myocardial infarction was present in 138 patients: these were further subdivided according to the treatments received: thrombolysis (rTPA or streptokinase), intravenous heparin, subcutaneous heparin and aspirin.
Early fibrinolytic, anticoagulant and antiplatelet therapy
All patients admitted to the Coronary Care Unit within 6 h of the onset of chest pain, who had diagnostic ST segment elevation and no contraindications, received thrombolytic treatment (42%).
Of the 138 patients with a larger anterior myocardial infarction, 68 (49%) were treated with thrombolytic therapy. Of these, 34 patients received streptokinase (1 500 000 IU i.v. over 1 h) and 34 had rTPA (100 mg i.v. in 2 h). The administration of both thrombolytics was immediately followed by heparin: a 5000 IU bolus followed by a continuous infusion, targeted to maintain the partial thromboplastin time ratio at about 2 (range 1 -7-2-3). Before discharge from the Coronary Care Unit, heparin was gradually tapered (median 6-5 range 4-12 days after MI). Antiplatelet therapy with aspirin (150 mg) was started on the first day of treatment in all patients.
Seventy patients with a larger anterior myocardial infarction did not receive fibrinolytic treatment, either because of contraindications (30 patients) or because of the late arrival (40 patients). Of these, 22 received intravenous (titrated to the partial thromboplastin time ratio) and 30 subcutaneous (25OOOIU daily) heparin. In both instances the drug was continued for the whole period of bed confinement (5 to 13 days). The remaining 18 patients, in whom anticoagulant therapy was also contraindicated, received only antiplatelet agents.
All patients studied underwent the following investigations. Two-dimensional echocardiography was performed by experienced operators unaware of the therapy each patient had received. Examinations were conducted using a Sonos 500 Hewlett Packard echocardiograph and employing a 2-5 or 3-5 MHz transducer, or both. In all patients, the examination was performed after discharge from the Coronary Care Unit, within 2 weeks of the acute event (average 10-2, range 7-15 days), when the patients were clinically stable and only took oral therapy.
Echocardiograms were recorded on videotape and reviewed in real time, slow motion and stop frame mode by three experienced echocardiographers, blinded to the study protocol. Each study included all standard echocardiographic views; left ventricular diameters were measured in the parasternal short axis at papillary muscle level.
Standard criteria for identifying left ventricular thrombus were used' 12 ' 131 and the diagnosis was established when the following conditions were met: (1) an echo-dense mass with distinct borders was identified in different echocardiographic views, and was easily visible throughout the cardiac cycle; (2) the wall motion of the adjacent myocardium was abnormal (dyskinetic or akinetic).
The regional wall motion was assessed in 18 left ventricular regions ( Fig. 1 ) which were assigned an asynergy score (0 = normal; l=hypokinesia; 2 = akinesia; 3 = dyskinesia). A global score was then obtained by adding individual segment values; the apical score was calculated from distal segments 13 
Coronary arteriography
Biplane left ventriculography (30°RAO and 60°LAO) and selective coronary angiography were performed by the Judkins technique in all patients within 3 weeks of the infarction. The left and right coronary arteries were imaged in multiple views, before and after intracoronary nitrates (200 \ig, slow bolus) to overcome the potential effects of vasoconstriction.
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Successful thrombolysis prevents LV thrombosis 423 Whenever present, coronary arterial lesions were evaluated semiquantitatively by two independent angiographers: end-diastolic cine frames were selected for optimal visualization of stenosis and magnified five times. Eccentric stenoses were evaluated in two orthogonal views. A normal arterial segment was identified immediately proximal and distal to the lesion and measured with a caliper. A stenosis was considered significant if it reduced the coronary diameter by at least 50%. If no significant lesions were present on the infarct-related artery, the location of irregularities of the vessel wall was also recorded.
Angiograms were also analysed for the presence of collaterals to the infarct region and Rentrop's scale was used for grading collaterals 1 ' 41 . Angiographic perfusion of the infarct zone was considered significant either when the infarct-related vessel was patent (with or without residual stenosis) and exhibited TIMI grade 2 or 3 flow or when Rentrop's grade 2 or 3 collaterals were present.
Follow-up
All patients were followed up for at least one month after the myocardial infarction and all embolic events identified both clinically and by laboratory investigations were recorded. Echo Doppler analysis of carotid arteries was performed in all patients who developed neurological ischaemic events.
Statistical analysis
Continuous data are expressed as mean ± SD. The chisquare test and two-tailed Student's t-test for unpaired data were used as appropriate. Correlations between continuous variables were assessed with multivariate regression analysis.
Differences were considered significant for a probability value of 0-05 or less.
Results
Left ventricular thrombus: relation to infarct location and type of treatment
Left ventricular thrombi were detected in 67 of the 418 study patients (16%). Table 1 shows the prevalence of left ventricular thrombus according to the site of myocardial infarction. Of the 85 patients initially presenting with ST segment depression or T wave inversion on the admission electrocardiogram, only three had left ventricular thrombus: all these patients eventually developed abnormal Q waves. The prevalence of thrombus was low in inferior infarctions (2-9%), but higher (6%) in the presence of posterolateral extension. Patients with a small area of anterior necrosis and exhibiting a similar asynergy score (inferoposterior: 12-5 ± 6-4, anterior: 13-9 ±73, P=ns) had a similar prevalence of left ventricular thrombus (7-3%). The highest prevalence was recorded in patients with anterior ST segment elevation and significant lesion or occlusion of the proximal left anterior descending coronary artery (39%).
Overall, the prevalence of thrombus in the different treatment groups (thrombolysis, i.v. heparin, s.c. heparin, aspirin) was not significantly different, probably because of the low prevalence (16%) in the whole study population. However, when the effects of treatment were assessed in the highest prevalence group (i.e. large anterior infarctions), statistically significant differences became apparent (Fig. 2) .
Patients receiving thrombolytics showed a lower prevalence of left ventricular thrombosis (26%) than the other patients (45%, P=004). Patients treated with either intravenous or subcutaneous heparin had a significantly (P<005) lower prevalence (respectively 45% and 47%) than those treated with aspirin, who exhibited a 67% prevalence. The difference was even more striking in patients treated with streptokinase (32%, P=003) and rt-PA (recombinant tissue plasminogen activator) (20%, P=Q-002). Patients undergoing thrombolysis had a 
heparin (P<005).
The five treatment groups were similar with regard to age, risk factors and concomitant treatment (Table 2) , except for lidocaine administration, because of the high incidence of reperfusion arrhythmias in thrombolysed patients.
Angiographic perfusion of the infarct are and left ventricular thrombus in anterior infarction
As shown in Fig. 3 , the patency of the infarct-related vessel was greater in thrombolysed patients than in the others (respectively 72% and 38%, P<005) and treatment with rt-PA more frequently resulted in anterograde perfusion (76%). Figure 4 summarizes the results obtained by analysing the relationship between thrombus, angiographic perfusion and the treatment received. Thrombolysed patients with TIMI 2-3 flow had a significantly lower prevalence of thrombus than those with an occluded vessel (respectively 14% and 54%, P<005). Those receiving thrombolytics and exhibiting a patent infarct-related vessel in association with an early creatine kinase peak, had the lowest prevalence (7%). Patients with coronary occlusion, but significant collateral flow to the infarct area also had a lower prevalence of left ventricular thrombosis than those without collaterals (respectively 37% and 54%, P<0-05).
Patients who only received heparin showed no difference in the prevalence of thrombus regardless of whether the infarct-related artery was patent or occluded; only two of these patients exhibited an early creatine kinase peak and none of them had thrombus.
Patients who did not receive thrombolytics or heparin had a very high prevalence of left ventricular thrombus (64%), especially in the absence of perfusion to the infarct area (75%). Only a few patients of this group had residual perfusion to the area of myocardial infarction; in these, the prevalence of left ventricular thrombus was lower, but the difference was not statistically significant.
Left ventricular function, thrombolysis and development of thrombus
No significant differences were found among the five treatment groups as regards the asynergy score (global and apical), the number of segments with hypokinesia, akinesia and dyskinesia and the left ventricular diameters. However, the ischaemic score was significantly lower in patients with a patent infarct-related artery, especially when associated with clinical signs of reperfusion. The decrease of both apical and global ischaemic score was accompanied by a parallel reduction in the prevalence of left ventricular thrombus (Fig. 5) . Multivariate regression analysis of the clinical and echocardiographic data obtained in the whole study group (Table 3) showed a highly significant correlation between the thrombus and the apical score (P=0-001) as well as the absence of angiographic perfusion to the infarct zone (/>=001).
Embolic events
Five patients developed embolic events (two strokes; two transient ischaemic attacks; one peripheral embolism). All had sustained an anterior myocardial infarction and four had a proximal-LAD lesion and left ventricular thrombus: only one of these received thrombolysis but without clinical and angiographic evidence of reper- fusion. Of five patients suffering an embolic event, only one had no echocardiographic evidence of thrombosis before and after the event; the angiographic study showed a significant stenosis of the left main coronary artery with severe reduction of left ventricular function, significant mitral regurgitation and left atrial enlargement. In the four patients with cerebrovascular accidents, echo Doppler examination of carotid arteries excluded significant local disease.
Discussion
Prevalence of left ventricular thrombosis in acute myocardial infarction
Our study confirms the results of previous reports by documenting the high prevalence of left ventricular thrombi in patients with anterior myocardial infarction [12ll5~17] . In fact, the overall incidence in our population was 31%.
Thrombus developed more frequently when the antero-apical region was involved and when the infarct area was large, as suggested by the strong relationship with the severity of the echocardiographic asynergy score. In fact, the highest incidence was observed in patients with a proximal LAD lesion or occlusion. Conversely, patients with ST segment elevation in inferior leads or ST segment depression had a low prevalence of thrombus (respectively 2-9 and 3-5%), and small dysfunctional areas. Indeed, the prevalence of thrombus increased when inferior necrosis extended towards the postero-lateral wall. When this was the case, the prevalence was similar to that observed in anterior myocardial infarctions of comparable extension. Patients' inclusion criteria, the dose of heparin and the time at which its administration was started vary quite widely in these reports, and may explain their conflicting results. Also, none of the previous studies separated large from small anterior infarctions: a different proportion of the two types in the study population might have significantly affected the prevalence of left ventricular thrombus. Moreover, not taking into account infarct size may represent a confounding factor for evaluating the potential effects of various treatments.
Fibrinolytic and anticoagulant therapy and left ventricular thrombus
Also, previous studies often showed significant differences in treatment strategies; in our study all patients underwent systemic thrombolysis, if not contraindicated, immediately followed by full anticoagulation with i.v. heparin. In addition, our study is the first one in which the patients were stratified according to the site of coronary occlusion and the size of the infarct area. There is no doubt that a balanced mix of severity, obtained by a large consecutive series, represents an advantage in the analysis of the results since anticoagulant and fibrinolytic therapies obviously cannot be randomized. Indeed, a statistically significant reduction in left ventricular thrombosis by fibrinolytic agents was evident only in patients with a large anterior myocardial infarction, probably because of the relatively low prevalence of thrombus observed in the other groups.
As in previous reports' 24 " 271 , anticoagulant therapy with heparin reduced the prevalence of thrombus regardless of the route of administration.
Reduction of left ventricular thrombus by thrombolysis: possible mechanisms
The mechanisms by which thrombolytic agents may reduce the prevalence of left ventricular thrombus have not been investigated. Theoretically, the effect may be related to the ability of these agents to directly lyse the thrombus; alternatively, the reduction may be secondary to the improvement of left ventricular function caused by an early reperfusion. Finally, a combination of the two mechanisms cannot be excluded. In the group of patients treated with full doses of i.v. heparin, the prevalence of left ventricular thrombus was lower than in patients who only received aspirin and similar regardless of whether the infarct-related artery was patent or not. Probably, the subsequent heparin therapy justifies the comparable incidence of thrombus observed in patients with thrombolysis was unsuccessful. The further reduction in the prevalence of thrombus was restricted to the patients who received thrombolytics and had reperfusion or whose myocardium was protected by collateral vessels.
Two previous studies reported a relationship between the absence of thrombus and the patency of the infarct-related vessel' 
Left ventricular thrombus and embolism
An increased risk of embolism has been demonstrated in patients with thrombi and our data agree with previous reports' 28 ' 291 : in the first month from the acute event we observed embolic complications only in patients with anterior myocardial infarction. The presence of left ventricular thrombus on echocardiography considerably increased the risk of this complication: among patients without evidence of thrombosis we observed only one case of transient ischaemic attack, whilst four events were recorded in patients with left ventricular thrombosis. In our series only patients with mobile, protruding thrombi and hyperkinesia of the adjacent myocardium received chronic anticoagulant therapy' 
Conclusions
These data suggest that left ventricular thrombosis development is inversely related to myocardial reperfusion of the infarct are and its timing. The evidence of a very low rate of left ventricular thrombosis in patients with patent vessels and early creatine kinase peak suggests that the salvage of myocardium at risk may be the mechanism by which thrombolytic agents are effective in reducing this complication.
The presence of left ventricular thrombus in a large anterior myocardial infarction identifies patients with reduced left ventricular function and may be a marker of unsuccessful thrombolytic therapy. A longterm follow-up with serial echocardiograms is ongoing in our institution and will hopefully provide further data on the value of ventricular thrombus detection for predicting left ventricular function outcome.
